Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (11)
P 1 (1)
P 2 (1)
P 4 (4)

Trial Status

Completed10
Unknown8
Recruiting3
Not Yet Recruiting2
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07373470Not ApplicableNot Yet RecruitingPrimary

An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.

NCT06660264Not ApplicableEnrolling By InvitationPrimary

An Evaluation of the Impact of Pharmacist Personalized Medication Reviews With and Without a Discussion of Pharmacogenomic Results in an Employee Health Program.

NCT03385473Not ApplicableCompletedPrimary

Individualized Antiretroviral Therapy

NCT06929533Not ApplicableRecruiting

Pharmacogenomics-Supported Psychotropic Prescribing Trial

NCT07041112Completed

Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

NCT04964310Recruiting

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

NCT05063838Not ApplicableUnknownPrimary

Perioperative Pharmacogenomic Testing

NCT05805241Recruiting

Pharmacogenetics Analysis of Fentanyl Administered in Newborns

NCT04893395Not ApplicableWithdrawnPrimary

Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans

NCT05247814Not Yet Recruiting

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

NCT05307718UnknownPrimary

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

NCT02937545Not ApplicableCompletedPrimary

Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting

NCT03154489Not ApplicableCompleted

Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care

NCT04449471Phase 4UnknownPrimary

Naproxen Pharmacogenetic Study (Project 1, Aim 2)

NCT03258151Unknown

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

NCT03258099Unknown

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

NCT03996356Unknown

Clozapine Induced Weight Gain

NCT03276598Phase 4Completed

A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

NCT02383290Not ApplicableCompletedPrimary

The Implementation of Pharmacogenomics Into Primary Care in British Columbia

NCT01970774Not ApplicableCompletedPrimary

Medication Therapy Management With Pharmacogenetic Testing

Scroll to load more

Research Network

Activity Timeline